| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,704 |
1,682 |
$98K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
884 |
860 |
$84K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,559 |
1,181 |
$49K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
182 |
182 |
$25K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
222 |
222 |
$19K |
| 99173 |
|
763 |
763 |
$17K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,740 |
1,737 |
$16K |
| 96127 |
|
1,021 |
1,013 |
$11K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
103 |
103 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
94 |
94 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
493 |
486 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
209 |
209 |
$4K |
| 90461 |
|
99 |
99 |
$4K |
| 99051 |
|
180 |
180 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
93 |
93 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
41 |
41 |
$495.81 |
| 92552 |
|
13 |
13 |
$212.03 |
| 94760 |
|
14 |
12 |
$35.42 |
| 90686 |
|
13 |
13 |
$0.00 |